Ftse Mib
34.475,55
0,04%
DAX
18.691,32
0,05%
S&P 500
5.315,04
0,15%
NASDAQ
16.942,05
0,84%
Bitcoin
68.080,10
-1,48%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Foamix Pharmaceuticals Ltd (FOMX) Foamix Pharmaceuticals Ltd (FOMX) Notizie

FOMX

Foamix Pharmaceuticals (FOMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FOMX
DataOraFonteTitoloSimboloCompagnia
23/03/202011:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/03/202020:10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021:34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202021:31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/03/202014:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202012:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/03/202012:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
09/03/202014:27Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FOMXFoamix Pharmaceuticals Ltd
03/03/202023:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/02/202023:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
28/01/202022:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
07/01/202022:51Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/11/201923:09PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/11/201912:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
19/08/201922:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
15/08/201923:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
06/08/201923:12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
18/04/201922:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
11/03/201911:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
08/03/201914:44Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
01/03/201923:04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/09/201822:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
02/04/201822:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
01/03/201822:31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
28/11/201722:06Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
14/09/201713:00PR Newswire (US)OWC Pharma Issues Chairman's Letter to ShareholdersNASDAQ:FOMXFoamix Pharmaceuticals Ltd
24/02/201722:07Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
21/02/201722:09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
12/09/201622:02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:FOMXFoamix Pharmaceuticals Ltd
10/03/201601:46GlobeNewswire Inc.Foamix to Present Corporate Overview at the 36th Annual Cowen & Company Healthcare ConferenceNASDAQ:FOMXFoamix Pharmaceuticals Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FOMX

La tua Cronologia

LSE
QH55
Morg.st.b.v 26
LSE
CODX
Codex Acquisitions
CREX
HLPBTC
Purpose Coin
LSE
63UE
Sant Uk Grp Sec
BIT
P1W7T0
NLBNPIT1W7T0 20240621 6.9
TG
MY4
Goodman
LBNK
DEDEUSDT
Dede
TG
2R7
Azelis Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network